Sirolimus (Rapamune)
Investigation : Sirolimus (Rapamune)
Specimen type : Whole Blood
Spec container : EDTA 
Volume required : 4 mL
Reference range : See below
Turnaround : 7 days

Sirolimus is a non-calcineurin inhibiting immunosuppresant drug given prophylactically to prevent organ rejection in kidney allograft recipients.

BTS guidelines do not suggest a target range, for interpretation please contact the appropriate clinical team looking after the patient for further information

An additional consideration is that mistiming of sampling in relation to medication can cause unexpected high/low levels of sirolimus and are not true trough levels.


Laboratory Services Home Page